WallStSmart

Oscar Health Inc (OSCR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Oscar Health Inc stock (OSCR) is currently trading at $12.21. Oscar Health Inc PS ratio (Price-to-Sales) is 0.31. Analyst consensus price target for OSCR is $15.40. WallStSmart rates OSCR as Sell.

  • OSCR PE ratio analysis and historical PE chart
  • OSCR PS ratio (Price-to-Sales) history and trend
  • OSCR intrinsic value — DCF, Graham Number, EPV models
  • OSCR stock price prediction 2025 2026 2027 2028 2029 2030
  • OSCR fair value vs current price
  • OSCR insider transactions and insider buying
  • Is OSCR undervalued or overvalued?
  • Oscar Health Inc financial analysis — revenue, earnings, cash flow
  • OSCR Piotroski F-Score and Altman Z-Score
  • OSCR analyst price target and Smart Rating
OSCR

Oscar Health Inc

NYSEHEALTHCARE
$12.21
$0.18 (1.50%)
52W$11.20
$23.80
Target$15.40+26.1%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Oscar Health Inc (OSCR) · 9 metrics scored

Smart Score

45
out of 100
Grade: D
Hold
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, eps growth, institutional own.. Concerns around return on equity and operating margin. Mixed signals suggest waiting for clearer direction before acting.

Oscar Health Inc (OSCR) Key Strengths (4)

Avg Score: 8.8/10
Price/SalesValuation
0.3110/10

Paying less than $1 for every $1 of annual revenue

EPS GrowthGrowth
47.20%10/10

Earnings per share surging 47.20% year-over-year

Institutional Own.Quality
65.57%8/10

65.57% held by institutions, strong professional interest

Market CapQuality
$3.58B7/10

Mid-cap company balancing growth potential with stability

Supporting Valuation Data

Price/Sales (TTM)
0.306
Undervalued
EV/Revenue
0.106
Undervalued

Oscar Health Inc (OSCR) Areas to Watch (5)

Avg Score: 2.0/10
Return on EquityProfitability
-44.40%0/10

Company is destroying shareholder value

Operating MarginProfitability
-11.90%0/10

Losing money on operations

Profit MarginProfitability
-3.79%0/10

Company is losing money with a negative profit margin

Price/BookValuation
3.664/10

Premium pricing at 3.7x book value

Revenue GrowthGrowth
17.30%6/10

Solid revenue growth at 17.30% per year

Supporting Valuation Data

Forward P/E
588.24
Expensive

Oscar Health Inc (OSCR) Detailed Analysis Report

Overall Assessment

This company scores 45/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 4 register as strengths (avg 8.8/10) while 5 fall into concern territory (avg 2.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, EPS Growth, Institutional Own.. Valuation metrics including Price/Sales (0.31) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 47.20%.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (3.66) suggest expensive pricing. Growth concerns include Revenue Growth at 17.30%, which may limit upside. Profitability pressure is visible in Return on Equity at -44.40%, Operating Margin at -11.90%, Profit Margin at -3.79%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -44.40% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 17.30% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

OSCR Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

OSCR's Price-to-Sales ratio of 0.31x sits near its historical average of 0.34x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 17% below its historical high of 0.37x set in Mar 2026, and -1% above its historical low of 0.31x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.3x as trailing revenue scaled faster than the stock price.

Compare OSCR with Competitors

Top HEALTHCARE PLANS stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Oscar Health Inc (OSCR) · HEALTHCAREHEALTHCARE PLANS

The Big Picture

Oscar Health Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 11.7B with 17% growth year-over-year. The company is currently unprofitable, posting a -3.8% profit margin.

Key Findings

Cash Flow Positive

Generating 663M in free cash flow and 672M in operating cash flow. Earnings are translating into actual cash generation.

Operating at a Loss

The company is unprofitable with a -3.8% profit margin. The path to breakeven will be the key catalyst.

What to Watch Next

Volatility is elevated with a beta of 1.90, so expect amplified moves relative to the broader market.

Sector dynamics: monitor HEALTHCARE PLANS industry trends, competitive moves, and regulatory changes that could impact Oscar Health Inc.

Bottom Line

Oscar Health Inc offers an attractive blend of growth (17% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Oscar Health Inc(OSCR)

Exchange

NYSE

Sector

HEALTHCARE

Industry

HEALTHCARE PLANS

Country

USA

Oscar Health, Inc. offers health insurance products and services to individuals, families, and businesses in the United States. The company is headquartered in New York, New York.

Visit Oscar Health Inc (OSCR) Website
75 VARICK STREET, NEW YORK, NY, UNITED STATES, 10013